Efficacy of Tramadol V/S Paroxetine for the Management of Premature Ejaculation Patients
Main Article Content
Abstract
Background: Premature ejaculation (PE) is a common sexual dysfunction in men, impacting relationships and quality of life. Current treatments include selective serotonin reuptake inhibitors (SSRIs) and opioid receptor agonists, but their comparative efficacy is not well-established.
Objective: To compare the efficacy of tramadol (an opioid receptor agonist) with paroxetine (an SSRI) in the treatment of PE.
Methods: This randomized control trial was conducted at Jinnah Postgraduate Medical Center, Karachi, from October 2020 to April 2021. Male patients aged 18-55 years, diagnosed with PE, were included. Exclusion criteria were erectile dysfunction, substance abuse, psychiatric illnesses, and ongoing PE treatment. Participants were divided into two groups: one receiving tramadol and the other paroxetine, taken 2-4 hours before intercourse. Efficacy was measured using Intravaginal Ejaculation Latency Time (IELT) over a six-week period. Data were analyzed using SPSS version 21, with a p-value of <0.05 considered significant.
Results: 200 participants were included, with 100 in each treatment group. Tramadol showed a higher efficacy (89% efficacy) compared to paroxetine (73% efficacy), with a significant p-value of 0.004. Stratified analyses by age, BMI, and duration of relationship also indicated higher efficacy for tramadol across different subgroups.
Conclusion: Tramadol demonstrated superior efficacy in delaying ejaculation compared to paroxetine in the treatment of PE. These findings suggest that tramadol may be a more effective alternative for PE management, although further research is needed to confirm these results and explore long-term outcomes.
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Premature ejaculation. European association of urology guidelines 2013.
Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med. 2014;11:1423-1441
Mohee A, Eardley I. Medical therapy for premature ejaculation. Ther Adv Urol. 2011;3 (5):211-22.
Gameel TA, Tawfik AM, Abou-Farha MO, Bastawisy MG, El-Bendary MA, El-Gamasy AE. On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: a randomised placebo-controlled clinical trial. Arab J Urol. 2013;11(4):392-7.
Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine ad hoc committee for the definition of premature ejaculation. J Sex Med 2014;11(60:1423-41.
Ho TT, Le MT, Truong QV, Nguyen VQ, Cao NT. Premature ejaculation and erectile dysfunction in male partners of infertile couples: prevalence and correlation. Fertil Reprod. 2019;1(03):126-30.
Wu T, Yue X, Duan X, Luo D, Cheng Y, Tian Y, et al. Efficacy and safety of tramadol for premature ejaculation: a systematic review and meta-analysis. Urology. 2012;80(3):618-24.
Ozcan L, Polat EC, Otunctemur A, Ozbek E. Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation. Int Urol Nephrol. 2015;47:283-287.
Gao J, Peng D, Zhang X, Hao Z, Zhou J, Fan S, et al. Prevalence and associated factors of premature ejaculation in the Anhui male population in China: evidence-based unified definition of lifelong and acquired premature ejaculation. Sex Med. 2017;5(1):e37-43.
Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet (London, England). 2006;368:929-937.
Kaynar M, Kilic O, Yurdakul T. On-demand tramadol hydrochloride use in premature ejaculation treatment. Urology. 2012;79:145-149.
Safarinejad MR. Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study. J Clin Psychopharmacol. 2008;28:39-44.
Pereira-Lourenço M, Brito DVE, Pereira BJ. Premature ejaculation: from physiology to treatment. J Family Reprod Health. 2019;13:120-131.
Bar-Or D, Salottolo KM, Orlando A, Winkler JV. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol. 2012;61:736-743.
Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51:816-823.
Giuliano F, Clément P. Serotonin and premature ejaculation: from physiology to patient management. Eur Urol. 2006;50:454-466.
Giuliano FA. Tramadol for the treatment of premature ejaculation. Eur Urol. 2012;61(4):744-5.
Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004;172: 290–4.
Hamidi-Madani A, Motiee R, Mokhtari G, Nasseh H, Esmaeili S, Kazemnezhad E. The efficacy and safety of on-demand tramadol and paroxetine use in treatment of life long premature ejaculation: a randomized double-blind placebo-controlled clinical trial. J Reprod Infertil. 2018;19(1):10.
Ur Rehman MF, Imran Zaidi A, Ul Haq T, Rafique S, Ali F. Comparison of the Efficacy of Tramadol and Paroxetine in the Management of Premature Ejaculation. Cureus. 2020 Sep 29;12(9):e10725. doi: 10.7759/cureus.10725.
21.Zhang D, Cheng Y, Wu K. Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis. BMC Urol. 2019;19:2 https://doi.org/10.1186/s12894-018-0431-7.
Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA. Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med. 2008;5(1):188-93.
Alghobary M, El-Bayoumy Y, Mostafa Y, Mahmoud el-HM, Amr M. Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation. J Sex Med. 2010;7(8):2860-7.
Patrick DL, Althof SE, Pryor JL, et al. ejaculatory disorders: premature ejaculation: an observational study of men and their partners. J Sex Med. 2005;2:358–367